Project Details
| Status | Active |
|---|---|
| Effective start/end date | 8/9/19 → 8/31/50 |
Funding
- Vertex Pharmaceuticals Incorporated
VX18-445-106-Part B: A Phase 3, Study Evaluating the Pharmacokinetics, Safety, and Tolerability of VX 445/TEZ/IVA Triple Combination Therapy in Cystic Fibrosis Subjects 6 Through 11 Years of Age
- McColley, Susanna A (PD/PI)
Project: Research project